The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC
- Type
- Retraction
- Notice date
- 1/21/2021 0:00
- Journal
- EBioMedicine
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.ebiom.2020.103169
- Original paper DOI
- 10.1016/j.ebiom.2018.10.044